China (Mainland)
Tenofovir Disoproxil Fumarate TDF exporter Tenofovir API supplier and manufacturerOffer 202138-50-9 CAS NO.202138-50-9
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Product Details
Keywords
- Tenofovir Disoproxil Fumarate TDF exporter
- Tenofovir API supplier and manufacturer
- Offer 202138-50-9
Quick Details
- ProName: Tenofovir Disoproxil Fumarate TDF expo...
- CasNo: 202138-50-9
- Molecular Formula: C23H34N5O14P
- Appearance: White to off-white crystalline powder
- Application: HIV, HBV
- DeliveryTime: 10 days after ordering
- PackAge: Two-layer LDPE bag and All Paper Drum
- Port: Any port in China
- ProductionCapacity: 200 Metric Ton/Year
- Purity: 98.0%~102.0% (on anhydrous basis)
- Storage: 2~8°C.
- Transportation: as per request
- LimitNum: 1 Kilogram
Superiority
Tenofovir Disoproxil Fumarate TDF exporter Tenofovir API supplier and manufacturerOffer 202138-50-9
Tenofovir fumarate
The nature of the
Melting point: 113-115 ° C
Storage conditions: Refrigerator
Appearance: powder
Color: White to Beige
CAS DataBase Reference 202138-50-9
Our advantage:
1. Deeply cultivated in chemical foreign trade for many years, rich industry exporter experience
2. Direct sales by chemical raw material manufacturers, low prices
3.Excellent scientific research team to ensure product quality and purity
4.Processing and production in large factories, realizing fast shipment
LONZEAL Pharmaceuticals was founded in 2006 and has become a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates, where ICH guidelines have been strictly applied in the whole chain of R&D, manufacturing process and quality management.
LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
Details
Tenofovir Disoproxil Fumarate TDF exporter Tenofovir API supplier and manufacturerOffer 202138-50-9
composition
The main ingredient of this product is tenofovir dipivoxil fumarate.
character
This product is tablet, oral powder.
indications
Children and adults over 1 and 2 years old are infected with HIV.
2. Chronic hepatitis B virus infection in children and adults over 12 years old.
specifications
(1) Tablet: 150mg; 200 mg; 250 mg; 300 mg.
(2) Oral powder: 40mg/g.
Usage.
The dosage and usage of this product may vary with different dosage forms and specifications. Please read the specific drug instructions for use or follow the doctor's advice.
1. For children and adults over 12 years old, the recommended oral dose is 300mg once, once per day. Those who cannot swallow the tablet can be given a 7.5-teaspoon powder.
The recommended dose for children aged 2-12 years is 8mg/kg (maximum dose 300mg), once a day. Oral powder can only be taken with the added dosage spoonful. One plain spoonful is 1g of powder containing 40mg of this product. The powder should be mixed with non-chewable soft foods (such as applesauce, yogurt, etc.) and taken immediately. Do not add powder to liquid. Powder will float on the surface of liquid and cannot be taken.
3. The dosage for patients with renal insufficiency is shown in the table below. Recommended dosages for renal insufficiency.
4. For patients receiving hemodialysis, the recommended dose is 300mg once every 7 days, or once after about 12h of hemodialysis (dialysis 3 times a week, also equivalent to once a week). Administration time should be after hemodialysis.
LONZEAL Pharmaceuticals was founded in 2006 and has become a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates, where ICH guidelines have been strictly applied in the whole chain of R&D, manufacturing process and quality management.
LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
LONZEAL is taking attentiveness and profession to build high quality products, and contributing to health and beautiful life for everyone in the world. The products and manufacturing site of Lonzeal have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
We have manufacturing site located in Hebei National Biomedical Industrial Zone, FPPs and APIs R&D Center of in Shijiazhuang Hi-tech Development Park, and the commercial office in Beijing, China.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.
Our advantage:
1. Deeply cultivated in chemical foreign trade for many years, rich industry exporter experience
2. Direct sales by chemical raw material manufacturers, low prices
3.Excellent scientific research team to ensure product quality and purity
4.Processing and production in large factories, realizing fast shipment